Henry Schein Inc (HSIC) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments.
Total Cash From Operating Activities Chart for Henry Schein Inc
Henry Schein Inc (HSIC) operating cash flow for FY2025 was USD 712.0M, a -16.0% change from FY2024. Henry Schein Inc's operating cash flow grew from USD 6.3M in 1994 to USD 712.0M in 2025 (11201.6% over 31 years). Operating cash flow compound annual growth rate: 5-year CAGR of 3.5%, 10-year CAGR of 2.0%, 20-year CAGR of 5.1%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $10.05B
- Implied Share Price
- $88.23
- Enterprise Value
- $13.81B
- Revenue (TTM)
- $13.60B
- EBITDA
- $1.08B
- Profit Margin
- 2.96%
- Trailing P/E
- 26.10
- Forward P/E
- 16.67
- Price/Book (MRQ)
- 3.22
- Price/Sales (TTM)
- 0.74
- EV/EBITDA
- 13.67
- EV/Revenue
- 1.02
- Dividend Yield
- —
- Book Value
- $28.21
- Free Cash Flow (FY2025)
- $573.00M
- Free Cash Flow Yield
- 5.70%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.